1.Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study
Eiichi Araki MD, Chantal Mathieu MD, Toshihiko Shiraiwa MD, Hajime Maeda MD, Hiroki Ikeda MD, Fredrik Thoren MD, Niki Arya MSc Michiko Asano MD, Nayyar Iqbal MD
Diabetes, Obesity and MetabolismEarly View
First published: 23 February 2021

 
2.Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study
Norihiro Kuroda, Yoshiki Kusunoki, Keiko Osugi, Mana Ohigashi, Daisuke Azuma, Hiroki Ikeda, Shinya Makino, Akihito Otsuka, Daisuke Tamada, Nobuaki Watanabe, Kahori Washio, Taku Tsunoda, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno, Hidenori Koyama, Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group
Journal of Diabetes InvestigationVolume 12, Issue 2
First published: 28 June 2020